Skip to main content

Vitiligo clinical trials at UC Irvine

4 in progress, 1 open to eligible people

Showing trials for
  • Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

    open to all eligible people

    TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

    Irvine, California and other locations

  • Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

    Sorry, not currently recruiting here

    This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

    Irvine, California and other locations

  • AMG 714 for Vitiligo

    Sorry, in progress, not accepting new patients

    This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.

    Irvine, California and other locations

  • Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

    Sorry, in progress, not accepting new patients

    To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

    Irvine, California and other locations

Our lead scientists for Vitiligo research studies include .

Last updated: